Helix Acquisition Corp. II (HLXB) Prices Upsized $160M IPO

Helix Acquisition Corp. II (Nasdaq: HLXB) announced the pricing of its upsized $160 million IPO this morning and its shares are expected to begin trading on the Nasdaq under the symbol “HLXB” today, Friday, February 9, 2024.

Helix Acquisition Corp. II intends to focus on target businesses in the healthcare or healthcare related industries.

The Company’s management team is comprised of Bihua Chen, Chairperson and Chief Executive Officer, Caleb Tripp, Chief Financial Officer, and Nebojsa Obradovic, Chief Legal Officer. Mark C. McKenna and John Schmid will each be a Director of the Company.

Total SPAC deal count for 2024 year-to-date is now 3. This offering is expected to close on Tuesday, February 13, 2024.

Leerink Partners is acting as the sole book-running manager for the offering. White & Case LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.